Carbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD.

Key Points

• The research examines the relationship between inhaler type selection and its effects on CO2 emissions and healthcare costs in COPD management.
• Comparative analysis of CO2 emissions from dry powder inhalers (DPIs) and pressurized metered-dose inhalers (pMDIs)
• Evaluation of healthcare resource utilization based on inhaler choice
• Assessment of clinical outcomes related to inhaler switching or initiation
• Non-clinically driven DPI use leads to CO2e emission savings, but also results in poorer clinical control.
• Increased emissions offset any savings from DPI use, due to higher healthcare utilization.
• Emissions from pMDIs with NGP are comparable to DPIs, warranting a reevaluation of prescribing guidelines.

Abstract